Study design and implementation
This was a single-center retrospective historical control study to
assess whether addition of eltrombopag to IST in SAA could improve the
hematological response and long-term efficacy in pediatric patients.
This study was approved by the Institutional Review Board of Beijing
Children’s Hospital, Capital Medical University. All the patients or
their legal guardians provided written informed consent.